Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of April 19, 2025, Denali Therapeutics (DNLI) has a market cap of $1.85 billion USD. According to our data, Denali Therapeutics is ranked No.4107 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Apr 19, 2025 | $1.85 B |
-36.93%
|
| Dec 31, 2024 | $2.93 B |
-5.03%
|
| Dec 29, 2023 | $3.09 B |
-22.83%
|
| Dec 30, 2022 | $4.00 B |
-37.65%
|
| Dec 31, 2021 | $6.42 B |
-46.75%
|
| Dec 31, 2020 | $12.05 B |
380.83%
|
| Dec 31, 2019 | $2.51 B |
-15.68%
|
| Dec 31, 2018 | $2.97 B |
32.10%
|
| Dec 29, 2017 | $2.25 B |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 Biogen
BIIB
|
$17.36 B |
-0.001 M
|
USA
|
 Eli Lilly
LLY
|
$754.27 B |
0.008 M
|
USA
|
 Novartis
NVS
|
$219.89 B |
0.932 B
|
Switzerland
|
 Pfizer
PFE
|
$125.57 B |
0.001 M
|
USA
|
 Johnson & Johnson
JNJ
|
$379.48 B |
-0.003 M
|
USA
|
 Merck
MRK
|
$196.28 B |
0.008 M
|
USA
|
 Sanofi
SNY
|
$124.64 B |
0.327 B
|
France
|
 Amgen
AMGN
|
$149.09 B |
0.124 B
|
USA
|
 Bristol-Myers Squibb
BMY
|
$100.17 B |
-0.004 M
|
USA
|
 AbbVie
ABBV
|
$306.02 B |
0.008 M
|
USA
|
 AstraZeneca
AZN
|
$210.29 B |
0.735 B
|
UK
|
 Gilead Sciences
GILD
|
$130.32 B |
-0.001 M
|
USA
|
 GlaxoSmithKline
GSK
|
$72.79 B |
-0.000 M
|
UK
|
 Regeneron Pharmaceuticals
REGN
|
$61.57 B |
1.023 B
|
USA
|
| Market Cap | = | DNLI Stock Price | * | DNLI Shares Outstanding |
| = | $12.74 | * | 0.15 B | |
| = | $1.85 B |